- Home
- CATX
as of 12-12-2025 3:45pm EST
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | SEATTLE |
| Market Cap: | 162.8M | IPO Year: | N/A |
| Target Price: | $11.56 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.45 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.60 - $5.39 | Next Earning Date: | 11-10-2025 |
| Revenue: | $1,075,000 | Revenue Growth: | -30.96% |
| Revenue Growth (this year): | -22.76% | Revenue Growth (next year): | -20.36% |
AI-Powered CATX Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Perspective Therapeutics Inc. (CATX)
Chief Accounting Officer
Avg Cost/Share
$2.03
Shares
11,000
Total Value
$22,294.80
Owned After
59,800
SEC Form 4
Director
Avg Cost/Share
$2.10
Shares
9,498
Total Value
$19,945.80
Owned After
9,864
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Hunt Jonathan Robert | CATX | Chief Accounting Officer | Nov 13, 2025 | Buy | $2.03 | 11,000 | $22,294.80 | 59,800 | |
| Williamson Robert F III | CATX | Director | Nov 12, 2025 | Buy | $2.10 | 9,498 | $19,945.80 | 9,864 |
Compare CATX vs Leading Stocks
See how CATX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CATX Perspective Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.